Skip to content

E-mental health treatment for patients with eye diseases (E-PsEYE): pilot study

E-mental health intervention for patients with retinal exudative diseases (E-PsEYE) who receive intra-ocular anti-VEGF injections: pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27788
Enrollment
20
Registered
2016-09-06
Start date
2016-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

e-mental health

Interventions

A cognitive behavioural therapy-based e-mental health intervention (offered via the Internet) will be investigated, consisting of nine modules designed to reduce depression and anxiety and increase ad

Sponsors

VU University Medical Centre Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in the pilot study: (1) patients should have at least mild symptoms of depression and/or anxiety (score of 5 or higher on the Patient Health Questionnaire (PHQ)-9, and/or score of 3 or higher on the Hospital Anxiety and Depression Scale – Anxiety (HADS-A)), (2) patients should be able to speak the Dutch language adequately, (3) patients should have access to the Internet, and (4) patients should be provide written informed consent to participate.

Exclusion criteria

Exclusion criteria: Patients are excluded from participation when: (1) they are cognitively impaired, which is assessed with a score <3 on the six-item Mini Mental State Examination (MMSE), (2) patients have a score of 20 or higher on PHQ-9, indicating severe symptoms of depression. These patients will be referred to their general practitioner to discuss other (more intensive) treatment options.

Design outcomes

Primary

MeasureTime frame
Depression symptomatology is measured with the PHQ-9 questionnaire. Anxiety symptomatology is measured with the HADS-A questionnaire. Both questionnaires are widely used and validated in a visually impaired sample.

Secondary

MeasureTime frame
Adaptation to vision loss is measured with the Adaptation to Vision Loss (AVL)-9 scale. Compliance is operationalized by patients rating their effort and social workers rating patients’ compliance to the intervention, based on a 10-point scale (0=no effort/compliance to 10=full effort/compliance). Patient satisfaction is measured with the Dutch Mental Healthcare (MH) thermometer of satisfaction: a widely used 20-item questionnaire providing information on patients’ satisfaction on provided information, relationship with the social worker, and results of the treatment.

Contacts

Public ContactH.P.A. Aa, van der

De Boelelaan 1117

h.vanderaa@vumc.nl+31 (0)20 4445064

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)